Segment Reporting - Summary of Financial Information with Respect to Reportable Segments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment revenues:
Total revenues	$ 137,931	$ 108,095	$ 85,543
Segment gross profit:
Total segment gross profit	65,620	63,472	49,093
Unallocated:
Research and development	(90,904)	(64,695)	(39,404)
Sales and marketing	(22,150)	(17,795)	(21,364)
General and administrative	(64,009)	(41,898)	(27,040)
(Loss) gain on equity investments	(1,781)	4,108	943
Change in fair value	11,359	28,263	9,922
Interest income	1,057	2,253	1,878
Income tax (expense) benefit	(411)	(345)	291
Net loss	(101,219)	(26,637)	(25,681)
Operating Segments | Software Segment
Segment revenues:
Total revenues	113,236	92,530	66,735
Segment gross profit:
Total segment gross profit	86,741	74,527	53,089
Operating Segments | Drug Discovery Segment
Segment revenues:
Total revenues	24,695	15,565	18,808
Segment gross profit:
Total segment gross profit	$ (21,121)	$ (11,055)	$ (3,996)